Get Diamond plan for FREE

    logo

    NewAmsterdam Pharma Company N.V. (NAMSW)

    Price:

    25.97 USD

    ( - 0 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    NAMSW
    Name
    NewAmsterdam Pharma Company N.V.
    Industry
    Biotechnology
    Sector
    Healthcare
    Price
    25.970
    Market Cap
    2.986B
    Enterprise value
    3.523B
    Currency
    USD
    Ceo
    Mayur Amrat Somaiya
    Full Time Employees
    68
    Website
    newamsterdampharma.com
    Ipo Date
    2021-02-10
    City
    Naarden
    Address
    Gooimeer 2-35

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    BioNTech SE

    VALUE SCORE:

    6

    Symbol
    BNTX
    Market Cap
    22.378B
    Industry
    Biotechnology
    Sector
    Healthcare

    2nd position

    ADMA Biologics, Inc.

    VALUE SCORE:

    11

    Symbol
    ADMA
    Market Cap
    3.864B
    Industry
    Biotechnology
    Sector
    Healthcare

    The best

    Harmony Biosciences Holdings, Inc.

    VALUE SCORE:

    12

    Symbol
    HRMY
    Market Cap
    1.552B
    Industry
    Biotechnology
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -20.301
    P/S
    182.258
    P/B
    6.054
    Debt/Equity
    0.000
    EV/FCF
    -24.398
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    160.492
    Earnings yield
    -0.049
    Debt/assets
    0.000
    FUNDAMENTALS
    Net debt/ebidta
    2.021
    Interest coverage
    0
    Research And Developement To Revenue
    6.303
    Intangile to total assets
    0.001
    Capex to operating cash flow
    -0.002
    Capex to revenue
    0.011
    Capex to depreciation
    1.118
    Return on tangible assets
    -0.265
    Debt to market cap
    0.000
    Piotroski Score
    1.000
    FUNDAMENTALS
    PEG
    -1.280
    P/CF
    -27.999
    P/FCF
    -27.706
    RoA %
    -26.495
    RoIC %
    -33.012
    Gross Profit Margin %
    99.738
    Quick Ratio
    7.876
    Current Ratio
    7.876
    Net Profit Margin %
    -905.742
    Net-Net
    4.963
    FUNDAMENTALS PER SHARE
    FCF per share
    -1.294
    Revenue per share
    0.197
    Net income per share
    -1.782
    Operating cash flow per share
    -1.292
    Free cash flow per share
    -1.294
    Cash per share
    5.562
    Book value per share
    5.974
    Tangible book value per share
    5.971
    Shareholders equity per share
    5.974
    Interest debt per share
    0.002
    TECHNICAL
    52 weeks high
    29.990
    52 weeks low
    5.450
    Current trading session High
    25.970
    Current trading session Low
    25.970
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -163.521
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -25.022
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -12.389
    logo
    Country
    BM
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    97.330
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -7.402
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -11.933
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -15.117
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -36.477
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    91.999
    logo
    Country
    CN
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -10.509
    DESCRIPTION

    NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases. Its lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), which has been clinically shown to reduce low-density lipoprotein cholesterol (LDL-C) while at the same time substantially increase high-density lipoprotein cholesterol (HDL-C). The company was founded in 2019 and is based in Naarden, the Netherlands.

    NEWS